#October 2017, #GLOBAL INDIAN
Dr B.R. Shetty is the Founder and Non-Executive Chairman of the Abu Dhabi based NMC Healthcare and Chairman of UAE Exchange, which most recently hit the headlines for its acquisition of forex major Travelex. The Karnataka-born and UAE-based entrepreneur opens up to ‘India Global Business’ on his journey, his inspirations and future plans.
What makes the UAE a good base for your enterprises?
In the last four decades, I have learnt so much about different cultures, made many Emirati friends and have realised that there is no place like the UAE to conduct business in.
I have got so many perspectives on life, learnt so much about world cultures that it has rounded me as a human being and a successful businessman. In the early Seventies, I came searching for a job and today, under the patronage of the royal family, I have 50,000 employees and a multi-billion-dollar empire spanning the globe.
With an open economy that has one of the world’s highest per capita income, with a sizeable annual trade surplus, the UAE has undergone an unprecedented transformation into a modern state with a high standard of living.
Some of the remarkable reasons for doing business in the UAE are: corporate tax and personal taxes are almost nil, import duties in the UAE are very low, there are Double Taxation Agreements, Free Trade Agreements and then there is a strong and competitive economy with a world-class infrastructure.
#April 2017, #The Americas
Despite the uncertainty of a Donald Trump regime, Indian companies proved they have some inbuilt resilience.
#February 2017, #Sector Focus/Pharma
The Indian pharmaceutical industry is holding on to a sliver of hope that it could become the supplier of choice for the US market.
Indian IT sector CEOs aren’t the only ones weighing every word uttered by US President Donald Trump for nuances and burning the midnight oil wondering how to maintain their lead in their largest market.
#Putting it in Context, #July/August 2016, #2016
I’m reminded of a famous line from William Shakespeare’s Julius Caesar, which says: “There is a tide in the affairs of men, which, taken at the flood, leads on to fortune; omitted, all the voyage of their life is bound in shallows and in miseries.”
We are now riding such a tide. Global economic flux and political uncertainty means world leaders need to figure out new relationships, new opportunities and reset the rules of engagement for a more connected and less secure than before world, where unprecedented migration and the movement of people for safety or for work is leading to anxiety.
These issues need to be…
#India-UK, #2016, #October 2016
Beats Mylan, Novartis, Torrent, Aurobindo to the post. Promoter says hungry for more
Almost inarguably, October 5th 2016, a Wednesday was the biggest day in the life of 53 year old Binish Hasmukh Chudgar, the highly low profile vice chairman of Ahmedabad based Intas Pharmaceuticals. That day in central London, Intas snapped up Israeli generic drug maker Teva’s assets in UK and Ireland—Actavis UK Ltd and Actavis Ireland Ltd—in a record $ 764 million deal (Rs 5083 crore) out muscling bigger global rivals like Mylan and Novartis or domestic competition like Aurobindo pharma and Torrent Pharmaceuticals in a bidding process that lasted over 6 months.
#July/August 2016, #2016, #Emerging Markets
The Indian Prime Minister sought to set the tone right and put India-Africa relations on a fast track with his recent African safari.
Narendra Modi’s five day four nation visit to Africa in July was his 51st visit to a foreign country since taking over and 11th this year. While his trips to US, Europe or China generate more newsprint and airwaves, his African safari is anything but less significant.
The continent has for long being seen as a potential bright spot in the world economy that will manifest itself after emerging markets like Russia, India, Brazil and China have exhausted themselves. When that happens, the country that has the most solid and traditional foundation and footprint…